Longtime Head of 9/11 Health Program Let Go Amid Federal Job Cuts
By I. Edwards HealthDay Reporter
THURSDAY, April 3, 2025 (HealthDay News) -- The longtime leader of a federal health program for 9/11 survivors and first...
Two Louisiana Infants Die of Whooping Cough Amid Drop in Vaccinations
By I. Edwards HealthDay Reporter
THURSDAY, April 3, 2025 (HealthDay News) -- Health experts are warning that whooping cough, also known as pertussis, is making...
FDA Removes Top Expert on Vaping and Tobacco
By I. Edwards HealthDay Reporter
WEDNESDAY, April 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration’s (FDA) top tobacco regulator, Brian King, has...
More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
Number of averted lung cancer deaths accounted for 51.4 percent of the estimated declines in overall cancer deaths
Major Job Cuts at NIOSH Pose Risks to Worker Safety, Critics Warn
By I. Edwards HealthDay Reporter
TUESDAY, April 1, 2025 (HealthDay News) -- A major round of job cuts at the National Institute for Occupational Safety...
Lung Cancer Screening Rates Increased After 2021 Update to USPSTF Guidelines
Lower odds of screening seen in association with lack of health insurance, being rural resident, not having a clinician
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts
NIH Ends Funding for the Effects of Climate Change on Health
By I. Edwards HealthDay Reporter
THURSDAY, March 27, 2025 (HealthDay News) -- The National Institutes of Health (NIH) will no longer fund new research on...
Tuberculosis on the Rise Again in the United States
Preliminary data show 2024 rates were highest seen in more than 12 years
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion
